文献速递糖尿病性腺与生殖内分泌

睾酮增加性腺功能减退合并2型糖尿病男性中AMP激酶α的表达与磷酸化

Testosterone Increases the Expression and Phosphorylation of AMP Kinase α in Men With Hypogonadism and Type 2 Diabetes.
PubMed 文献 · J Clin Endocrinol Metab · 2020-01-01

本研究为一项已完成试验的二次分析,比较32例低促性腺激素性性腺功能减退(HH)男性与32例性腺功能正常男性的骨骼肌和腹部皮下脂肪中AMPKα表达与磷酸化,并观察睾酮或安慰剂肌内注射每2周1次、共22周前后的变化。结果显示HH患者AMPKα表达与磷酸化降低,睾酮治疗后在钳夹后阶段明显升高。

要点

  • HH男性脂肪组织AMPKα mRNA表达较性腺功能正常男性低37%,骨骼肌低29%。
  • 睾酮治疗后钳夹后脂肪组织与肌肉AMPKα表达分别升高41%和46%,空腹状态无变化。
  • 睾酮治疗后肌肉磷酸化AMPKα升高69%,钳夹后未再变化。

核心结论

  • 睾酮调节AMPKα表达与磷酸化AMPKα,这些效应可能有助于睾酮治疗后胰岛素敏感性的改善。

研究设计与样本

  • 本研究为一项已完成试验的二次分析,该试验曾显示睾酮治疗对2型糖尿病合并HH男性具有胰岛素增敏效应。
  • 基线比较32例HH男性与32例性腺功能正常男性。
  • HH男性接受睾酮或安慰剂肌内注射,每2周1次,共22周。
  • 于睾酮或安慰剂治疗前后,在4小时正常血糖高胰岛素钳夹前后行股四头肌与腹部皮下脂肪活检。

主要发现

  • HH男性脂肪组织AMPKα mRNA表达较性腺功能正常男性低37%,骨骼肌低29%。
  • HH男性磷酸化AMPKα在脂肪组织较性腺功能正常男性低22%,在骨骼肌低28%。
  • 睾酮替代后空腹状态AMPKα表达未改变,钳夹后脂肪组织与肌肉AMPKα表达分别明显升高41%和46%。
  • 睾酮治疗后肌肉磷酸化AMPKα升高69%,钳夹后未变化。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Adenosine 5'-monophosphate-activated protein kinase-α (AMPKα) is a mediator of exercise-induced glucose uptake in skeletal muscle. OBJECTIVE: We evaluated whether AMPKα expression and phosphorylation are reduced in skeletal muscle and adipose tissue of patients with hypogonadotropic hypogonadism (HH), and whether testosterone replacement therapy results in restoration of the expression and phosphorylation of AMPKα. DESIGN: This is a secondary analysis of a previously completed trial that showed an insulin-sensitizing effect of testosterone therapy in men with type 2 diabetes and HH. SETTING: Clinical research center at university. PATIENTS: Thirty-two men with HH and 32 eugonadal men were compared at baseline. INTERVENTIONS: Men with HH were treated with intramuscular injections of testosterone or placebo every 2 weeks for 22 weeks. Quadriceps muscle biopsies and subcutaneous abdominal fat biopsies were obtained before and after 4-hour euglycemic hyperinsulinemic clamp, prior to and after testosterone or placebo therapy. OUTCOME MEASURES AND RESULTS: mRNA expression of AMPKα in hypogonadal men was lower by 37% in adipose tissue and 29% in skeletal muscle, respectively, compared with levels in eugonadal men, while phosphorylated AMPKα was lower by 22% and 28%, respectively. Following testosterone replacement, the expression of AMPKα did not alter in the fasting state but increased markedly by 41% and 46% in adipose tissue and muscle, respectively, after the clamp. In contrast, phosphorylated AMPKα increased by 69% in muscle after testosterone therapy but did not change following the clamp. CONCLUSIONS: Testosterone modulates the expression of AMPKα and phosphorylated AMPKα. These effects may contribute to the improved insulin sensitivity following testosterone therapy.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Ghanim H, Dhindsa S, Batra M, et al. Testosterone Increases the Expression and Phosphorylation of AMP Kinase α in Men With Hypogonadism and Type 2 Diabetes. J Clin Endocrinol Metab. 2020. PMID: 31858126. doi:10.1210/clinem/dgz288

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。